While some mutations in the BRCA2 gene clearly indicate risks for breast and prostate cancer, thousands of less-common variations have confounded doctors and left anxious patients without guidance ...

A Mayo Clinic-led team of researchers is solving one of the most frustrating aspects of genetic cancer screening — results ...

A recent study that focused on women under 55 years old found an increase in pancreatic cancer cases. Mercy Medical Center Dr ...

A recent study that focused on women under 55 years old found an increase in pancreatic cancer cases.Mercy Medical Center Dr.

Scientists at Children's Medical Research Institute have solved a big mystery in cancer research – why cells die in different ...

Allison Kurian and Jennifer Caswell-Jin will lead the PROACT program, a new breast and ovarian cancer initiative to improve ...

A groundbreaking study led by the Mayo Clinic Comprehensive Cancer Center has significantly deepened our understanding of ...

"I just wish someone had told me this was a possibility." Kara Maxwell distinctly remembers the moment she heard those words ...

The institute originally began reviewing Lynparza in this setting in 2018 but ended its review due to lack of evidence.

Breast Cancer Now said olaparib will be an ‘valuable alternative’ for patients with a certain type of secondary breast cancer ...

"It's fantastic news that olaparib has been approved for use on the NHS in England, providing a second targeted treatment option for certain people with locally advanced or secondary breast cancer who ...

Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center have significantly advanced the understanding of genetic alterations in the ...